$7.35
0.304.26%
Últ. Act.: Oct 23, 6:47 PM
Sophia Genetics (SOPH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Sophia Genetics (SOPH) publicó su última previsión de agosto 4, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $94M - $96M para el período.
En comparación con la previsión anterior, Sophia Genetics elevado redujo su previsión de ingresos desde un rango anterior de $92M - $94M.
Sophia Genetics ha emitido 14 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 4, 2026. During this period, the company raised its outlook 7 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.24 | $-0.20 | $-0.20 |
| Actual | $-0.30 | $-0.27 | $-0.28 | $-0.30 |
| Surprise | -36.4% | -12.5% | -40.0% | -50.0% |
| Revenue | ||||
| Estimate | $21.6M | $20.4M | $20.9M | $18.1M |
| Actual | $23.3M | $21.7M | $21.7M | $19.5M |
| Surprise | +7.84% | +6.29% | +3.92% | +7.36% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.19 | $-0.14 | $-0.09 | $-0.08 |
| Revenue | ||||
| Consensus | $24.0M | $26.3M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.30 | $-0.22 | -36.4 % |
| Q1 | May 5, 2026 | $-0.27 | $-0.24 | -12.5 % |
| Q4 | Mar 3, 2026 | $-0.28 | $-0.20 | -40.0 % |
| Q3 | Nov 4, 2025 | $-0.30 | $-0.20 | -50.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $23.31M | $21.62M | 7.84 % |
| Q1 | May 5, 2026 | $21.69M | $20.40M | 6.29 % |
| Q4 | Mar 3, 2026 | $21.71M | $20.89M | 3.92 % |
| Q3 | Nov 4, 2025 | $19.46M | $18.13M | 7.36 % |